• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

fatty liver disease

Biotech

Madrigal's stock enters orbit after 2nd phase 3 NASH success

The tricky indication of nonalcoholic steatohepatitis has confounded many, but Madrigal Pharmaceuticals thinks it's finally onto a winner.
James Waldron Dec 19, 2022 10:05am

Nicotine-nomming gut bacteria could protect against NASH

Oct 21, 2022 1:05pm

Rivus raises $132M series B as metabolic pipeline heats up

Sep 22, 2022 10:41am

Pfizer gains fast-track tag for previously shelved NASH drug

May 26, 2022 9:05am

89bio gains a little more confidence in NASH treatment

Mar 25, 2022 11:00am

Rivus throws down liver fat data on quest to climb NASH mountain

Feb 9, 2022 9:27am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy